Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Treasury Share Holdings

Bulletin Express01-16

Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 16 January 2026. The company repurchased 45,000 ordinary shares, resulting in an adjusted total of 225,286,000 issued shares (excluding treasury shares) and 1,785,600 treasury shares as of the same date. The repurchase price ranged between HKD 22.98 and HKD 23.32 per share, with an aggregate consideration of HKD 1,041,174.

The repurchase was conducted under a mandate dated 20 June 2025, which authorized the repurchase of up to 22,207,160 shares. To date, a total of 1,785,600 shares have been repurchased under the mandate, representing approximately 0.8041% of the issued shares referenced at the time the mandate was granted.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187095824?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-16 21:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187095824","market":"hk","top_or_hot":-1,"title":"Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Treasury Share Holdings","media":"Bulletin Express","content":"<p>Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 16 January 2026. The company repurchased 45,000 ordinary shares, resulting in an adjusted total of 225,286,000 issued shares (excluding treasury shares) and 1,785,600 treasury shares as of the same date. The repurchase price ranged between HKD 22.98 and HKD 23.32 per share, with an aggregate consideration of HKD 1,041,174.</p>\n<p>The repurchase was conducted under a mandate dated 20 June 2025, which authorized the repurchase of up to 22,207,160 shares. To date, a total of 1,785,600 shares have been repurchased under the mandate, representing approximately 0.8041% of the issued shares referenced at the time the mandate was granted.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Treasury Share Holdings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQyuns Therapeutics (02509) Announces Share Repurchase and Updated Treasury Share Holdings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-01-16 21:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 16 January 2026. The company repurchased 45,000 ordinary shares, resulting in an adjusted total of 225,286,000 issued shares (excluding treasury shares) and 1,785,600 treasury shares as of the same date. The repurchase price ranged between HKD 22.98 and HKD 23.32 per share, with an aggregate consideration of HKD 1,041,174.</p>\n<p>The repurchase was conducted under a mandate dated 20 June 2025, which authorized the repurchase of up to 22,207,160 shares. To date, a total of 1,785,600 shares have been repurchased under the mandate, representing approximately 0.8041% of the issued shares referenced at the time the mandate was granted.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02509","symbol_name":"荃信生物-B","start_time":0,"source_url":"","article_id":"1187095824","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187095824","pubTimestamp":1768569753,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 16 January 2026. The company repurchased 45,000 ordinary shares, resulting in an adjusted total of 225,286,000 issued shares...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02509":"荃信生物-B"},"translate_title":"Qyuns Therapeutics(02509)宣布回购股份及更新库存股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02509":1},"content_text":"Qyuns Therapeutics Co., Ltd. (02509) disclosed a share repurchase on 16 January 2026. The company repurchased 45,000 ordinary shares, resulting in an adjusted total of 225,286,000 issued shares (excluding treasury shares) and 1,785,600 treasury shares as of the same date. The repurchase price ranged between HKD 22.98 and HKD 23.32 per share, with an aggregate consideration of HKD 1,041,174.\nThe repurchase was conducted under a mandate dated 20 June 2025, which authorized the repurchase of up to 22,207,160 shares. To date, a total of 1,785,600 shares have been repurchased under the mandate, representing approximately 0.8041% of the issued shares referenced at the time the mandate was granted.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187095824","isCrawlerRequest":true}